BioCardia, Inc. (BCDA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-76.9%

$0.21

vs $0.90 price

Levered DCF

$0.30

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-51.25

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-1.02×	-0.75×	-1.22×	-9.36×	-7.8×	-7.01×	-4.23×	-9.96×
P/B	9.31×	7.15×	-8.77×	22.71×	9.49×	5.48×	26.29×	36.43×
P/S	0×	103.14×	29.48×	82.15×	97.02×	724.36×	87.77×	221.06×
EV / EBITDA	-0.82×	-0.58×	-1.24×	-8.91×	-6.96×	-5.64×	-3.99×	-9.55×
Gross margin	0.0%	-7463.8%	-1519.7%	-553.4%	36.9%	97.2%	49.6%	17.3%
Operating margin	0.0%	-13794.8%	-2441.1%	-880.3%	-1244.3%	-10709.7%	-2001.8%	-2256.3%
Net margin	0.0%	-13700.0%	-2425.8%	-880.7%	-1243.4%	-10347.6%	-2071.7%	-2237.9%
Current ratio	1.12×	1.13×	0.4×	2.19×	3.63×	5.33×	1.59×	2.44×
Debt / equity	0.59×	1.14×	-0.82×	0.33×	0.18×	0.03×	0.48×	0×
Interest coverage	0×	0×	0×	-1,983.5×	0×	-5,176.33×	-126.9×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-919.3%	-949.3%	721.8%	-243.4%	-121.6%	-78.2%	-620.6%	-368.9%
Return on invested capital	-581.7%	-447.5%	4057.1%	-182.5%	-103.2%	-78.5%	-338.2%	-361.5%
Return on assets	-241.1%	-213.4%	-387.4%	-121.6%	-80.3%	-64.1%	-191.6%	-218.0%
Free cash flow yield	-89.3%	-134.3%	-71.0%	-9.6%	-10.6%	-11.8%	-15.4%	-8.1%
Earnings yield	-98.7%	-132.8%	-82.3%	-10.7%	-12.8%	-14.3%	-23.6%	-10.1%
Enterprise value	$6.4M	$4.6M	$14.3M	$105.3M	$87.5M	$84.2M	$57.9M	$132.8M
Net debt / EBITDA	0.25×	0.18×	-0.02×	0.48×	0.88×	1.39×	0.31×	0.39×
Cash conversion cycle (days)	-463	-32	6	26	-236	-67,489	-852	-265